The Contribution of cocoa additive to cigarette smoking addiction
The Contribution of cocoa additive to cigarette smoking addiction The Contribution of cocoa additive to cigarette smoking addiction
Page 156 of 207 RIVM report 650270002 Phenylethylamine Phenylethylamine (5 mg) produced symptoms like headache, dizziness and discomfort in some volunteers (n = 27). The LD50 value in rats varies between 100 mg/kg (i.p.) to 800 mg/kg (oral). No data are available on the inhalation toxicological effect of phenylethylamine. Therefore, no conclusion can be drawn whether the phenylethylamine dose in one cigarette (0.49 mg/cigarette) will exert significant systemic and local toxicological effects. Phenylethylamine reacts with aldehydes and cyanides in cigarettes and forms adducts with those cigarette components. These adducts have MAOI properties. MAO metabolises phenylethylamine in the pulmonary system. Therefore, MAOI increase the phenylethylamine level in the body. It is plausible that phenylethylamine availability from cigarette smoking will be increased when MAO is inhibited. Phenylethylamine has reinforcing properties qualitatively comparable to amphetamine. Whether phenylethylamine in cigarette plays a role in the reinforcing effect of cigarette smoking is unknown. Phenylethylamine could be used to treat depression disorder in human. Whether phenylethylamine in cigarette plays a role in the possible anti-depressive effect of cigarette smoking is unknown. Based on the metabolisation by MAO, it seems that pulmonary MAO will reduce the bioavailability of phenylethylamine through cigarette smoking. However, since no data are available on pharmacodynamic, pharmacokinetic and toxicological effects of phenylethylamine exposure through inhalation, the shortterm and longterm effects of exposure to phenylethylamine through smoking on the respiratory system cannot be established. Furthermore, its additive effects on other biogenic amines present in cigarette smoke are also not known and have to be studied. More studies are needed on: - the determination of pyrolysis/combustion products of phenylethylamine in cigarette smoke; - the local (respiratory system) effects of long-term use of phenylethylamine alone and its pyrolysis/combustion products via inhalation; - the local (respiratory system) effects of long-term use of phenylethylamine in combination with other biogenic amines via inhalation. - Biavailability of phenylethylamine via respiratory exposure Date this sheet was generated Based on literature available in march 2002. REFERENCES (1) Dictionary of substances and their effects (DOSE). The Royal Society of Chemistry, editor version 10/2000, 2001. Electronic version. (2) Brandweerinformatiecentrum voor gevaarlijke stoffen (BIG). Electronic version
RIVM report 650270002 Page 157 of 207 Phenylethylamine 9.0, 2001. Belgium. (3) The Hazardous Substances Data Bank (HSDB). HSDB . 1-1-2001, Electronic version. (4) Chemfinder website: http://chemfinder.cambridgesoft.com/ chemfinder . 2001. (5) The Merck Index, version 12:1, 1996. Electronic version by Chapman & Hall EPD. (6) Etienne Perdrizet, Jacques Prevost. Aliphatic and aromatic amines during development of nicotiana tabacum. Phytochemistry, 1981; 20(9):2131-2134. (7) Roemer E, Hackenberg U. Mouse skin bioassay of smoke condensates from cigarettes containing different levels of cocoa. Food Addit Contam, 1990; 7(4):563-569. (8) Baker GB, Wong JT, Coutts RT, Pasutto FM. Simultaneous extraction and quantitation of several bioactive amines in cheese and chocolate. Journal of chromatography, 1987; 392317-31:-31. (9) ten Brink B, Damink C, Joosten HM, Huis-in-'t-Veld-JH. Occurrence and formation of biologically active amines in foods. Int J Food Microbiol, 1990; 11 (1):73-84. (10) Kawamura K, Matsumoto T, Nakahara T, Hirano M, Uchimura H, Maeda H. Improved method for determination of .beta.-phenylethylamine in human plasma by solid-phase extraction and high-performance liquid chromatography with fluorescence detection. J Liq Chromatogr Relat Technol, 2000; 23 (13):1981-1993. (11) Paterson IA, Juorio A, V, Boulton AA. 2-Phenylethylamine: a modulator of catecholamine transmission in the mammalian central nervous system? J Neurochem, 1990; 55 (6):1827-1837. (12) Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL et al. Trace amines: Identification of a family of mammalian G protein-coupled receptors. Proceedings of the National Academy of Sciences of the United States of America, 2001; 98(16):8966-8971. (13) Hawthorn MH, Broadley KJ, Gibbon CJ. Examination of the bronchoconstrictor response of guinea-pig isolated lung to beta-phenylethylamine. Gen Pharmacol, 1985; 16 (4):371-378. (14) Liang CS, Sprecher D. Cardiovascular actions of beta-phenylethylamine. The American journal of physiology, 1979; 236 (4):H592-H595. (15) Shannon HE, Cone EJ, Yousefnejad D. Physiologic effects and plasma kinetics of beta-phenylethylamine and its N-methyl homolog in the dog. The Journal of pharmacology and experimental therapeutics, 1982; 223 (1):190-196. (16) Sabelli HC, Javaid JI. Phenylethylamine modulation of affect: therapeutic and
- Page 105 and 106: RIVM report 650270002 Page 105 of 2
- Page 107 and 108: RIVM report 650270002 Page 107 of 2
- Page 109 and 110: RIVM report 650270002 Page 109 of 2
- Page 111 and 112: RIVM report 650270002 Page 111 of 2
- Page 113 and 114: RIVM report 650270002 Page 113 of 2
- Page 115 and 116: RIVM report 650270002 Page 115 of 2
- Page 117 and 118: RIVM report 650270002 Page 117 of 2
- Page 119 and 120: RIVM report 650270002 Page 119 of 2
- Page 121 and 122: RIVM report 650270002 Page 121 of 2
- Page 123 and 124: RIVM report 650270002 Page 123 of 2
- Page 125 and 126: Page 125 of 207 RIVM report 6502700
- Page 127 and 128: RIVM report 650270002 Page 127 of 2
- Page 129 and 130: RIVM report 650270002 Page 129 of 2
- Page 131 and 132: RIVM report 650270002 Page 131 of 2
- Page 133 and 134: RIVM report 650270002 Page 133 of 2
- Page 135 and 136: RIVM report 650270002 Page 135 of 2
- Page 137 and 138: RIVM report 650270002 Page 137 of 2
- Page 139 and 140: RIVM report 650270002 Page 139 of 2
- Page 141 and 142: RIVM report 650270002 Page 141 of 2
- Page 143 and 144: RIVM report 650270002 Page 143 of 2
- Page 145 and 146: RIVM report 650270002 Page 145 of 2
- Page 147 and 148: RIVM report 650270002 Page 147 of 2
- Page 149 and 150: RIVM report 650270002 Page 149 of 2
- Page 151 and 152: RIVM report 650270002 Page 151 of 2
- Page 153 and 154: RIVM report 650270002 Page 153 of 2
- Page 155: RIVM report 650270002 Page 155 of 2
- Page 159 and 160: RIVM report 650270002 Page 159 of 2
- Page 161 and 162: RIVM report 650270002 Page 161 of 2
- Page 163 and 164: RIVM report 650270002 Page 163 of 2
- Page 165 and 166: RIVM report 650270002 Page 165 of 2
- Page 167 and 168: RIVM report 650270002 Page 167 of 2
- Page 169 and 170: RIVM report 650270002 Page 169 of 2
- Page 171 and 172: RIVM report 650270002 Page 171 of 2
- Page 173 and 174: RIVM report 650270002 Page 173 of 2
- Page 175 and 176: RIVM report 650270002 Page 175 of 2
- Page 177 and 178: RIVM report 650270002 Page 177 of 2
- Page 179 and 180: RIVM report 650270002 Page 179 of 2
- Page 181 and 182: RIVM report 650270002 Page 181 of 2
- Page 183 and 184: RIVM report 650270002 Page 183 of 2
- Page 185 and 186: RIVM report 650270002 Page 185 of 2
- Page 187 and 188: RIVM report 650270002 Page 187 of 2
- Page 189 and 190: RIVM report 650270002 Page 189 of 2
- Page 191 and 192: RIVM report 650270002 Page 191 of 2
- Page 193 and 194: RIVM report 650270002 Page 193 of 2
- Page 195 and 196: RIVM report 650270002 Page 195 of 2
- Page 197 and 198: RIVM report 650270002 Page 197 of 2
- Page 199 and 200: RIVM report 650270002 Page 199 of 2
- Page 201 and 202: RIVM report 650270002 Page 201 of 2
- Page 203 and 204: RIVM report 650270002 Page 203 of 2
- Page 205 and 206: RIVM report 650270002 Page 205 of 2
RIVM report 650270002 Page 157 <strong>of</strong> 207<br />
Phenylethylamine<br />
9.0, 2001. Belgium.<br />
(3) <strong>The</strong> Hazardous Substances Data Bank (HSDB). HSDB . 1-1-2001, Electronic<br />
version.<br />
(4) Chemfinder website: http://chemfinder.cambridges<strong>of</strong>t.com/ chemfinder . 2001.<br />
(5) <strong>The</strong> Merck Index, version 12:1, 1996. Electronic version by Chapman & Hall<br />
EPD.<br />
(6) Etienne Perdrizet, Jacques Prevost. Aliphatic and aromatic amines during<br />
development <strong>of</strong> nicotiana tabacum. Phy<strong>to</strong>chemistry, 1981; 20(9):2131-2134.<br />
(7) Roemer E, Hackenberg U. Mouse skin bioassay <strong>of</strong> smoke condensates from<br />
<strong>cigarette</strong>s containing different levels <strong>of</strong> <strong>cocoa</strong>. Food Addit Contam, 1990;<br />
7(4):563-569.<br />
(8) Baker GB, Wong JT, Coutts RT, Pasut<strong>to</strong> FM. Simultaneous extraction and<br />
quantitation <strong>of</strong> several bioactive amines in cheese and chocolate. Journal <strong>of</strong><br />
chroma<strong>to</strong>graphy, 1987; 392317-31:-31.<br />
(9) ten Brink B, Damink C, Joosten HM, Huis-in-'t-Veld-JH. Occurrence and<br />
formation <strong>of</strong> biologically active amines in foods. Int J Food Microbiol, 1990; 11<br />
(1):73-84.<br />
(10) Kawamura K, Matsumo<strong>to</strong> T, Nakahara T, Hirano M, Uchimura H, Maeda H.<br />
Improved method for determination <strong>of</strong> .beta.-phenylethylamine in human<br />
plasma by solid-phase extraction and high-performance liquid chroma<strong>to</strong>graphy<br />
with fluorescence detection. J Liq Chroma<strong>to</strong>gr Relat Technol, 2000; 23<br />
(13):1981-1993.<br />
(11) Paterson IA, Juorio A, V, Boul<strong>to</strong>n AA. 2-Phenylethylamine: a modula<strong>to</strong>r <strong>of</strong><br />
catecholamine transmission in the mammalian central nervous system? J<br />
Neurochem, 1990; 55 (6):1827-1837.<br />
(12) Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL et<br />
al. Trace amines: Identification <strong>of</strong> a family <strong>of</strong> mammalian G protein-coupled<br />
recep<strong>to</strong>rs. Proceedings <strong>of</strong> the National Academy <strong>of</strong> Sciences <strong>of</strong> the United<br />
States <strong>of</strong> America, 2001; 98(16):8966-8971.<br />
(13) Hawthorn MH, Broadley KJ, Gibbon CJ. Examination <strong>of</strong> the bronchoconstric<strong>to</strong>r<br />
response <strong>of</strong> guinea-pig isolated lung <strong>to</strong> beta-phenylethylamine. Gen Pharmacol,<br />
1985; 16 (4):371-378.<br />
(14) Liang CS, Sprecher D. Cardiovascular actions <strong>of</strong> beta-phenylethylamine. <strong>The</strong><br />
American journal <strong>of</strong> physiology, 1979; 236 (4):H592-H595.<br />
(15) Shannon HE, Cone EJ, Yousefnejad D. Physiologic effects and plasma kinetics<br />
<strong>of</strong> beta-phenylethylamine and its N-methyl homolog in the dog. <strong>The</strong> Journal <strong>of</strong><br />
pharmacology and experimental therapeutics, 1982; 223 (1):190-196.<br />
(16) Sabelli HC, Javaid JI. Phenylethylamine modulation <strong>of</strong> affect: therapeutic and